ðŸð± ç¬ç«ãã¥ãŒã¹ â 2026.06.18
ç¬4 ïŒ ç«2 ïŒ èš6ä»¶
ðŸ ç¬ãã¥ãŒã¹ â 2026.06.18
æ¬æ¥ 4ä»¶
1. â ïž å»çã»çŸç ã»äºé²
60幎ã¶ãã«ç±³åœã«åäžéžãããã©ã»ã³ãŠãžããšïŒæ°äžçã©ã»ã³ãŠãžçïŒããã€ãã«ç¬ã«ãå¯ç確èªââFDAãç¬ç«åãé§è«è¬ãç·æ¥äœ¿çšèš±å¯
ð 2026.06.11
çããçµç¹ãé£ãèããããšã®å¹Œè«ãåŒãèµ·ãããæ°äžçã©ã»ã³ãŠãžçïŒNew World ScrewwormïŒNWSïŒãããç±³åœã§60幎ã¶ãã«åç©ãžã®å¯çãšããŠç¢ºèªããããUSDAã®éèšã§ã¯2026幎6æ11æ¥æç¹ã§ç¢ºèªäŸã¯9ä»¶ã«å¢ãããããµã¹å·ã»ãã¥ãŒã¡ãã·ã³å·ã§çã»ã€ã®ã«å ããŠç¬1é ã§ã®ææãå ±åããããåå ã®Cochliomyia hominivoraxã¯æ°ããå·ã錻ã»å£ã»è³ã»é°éšãªã©ã®ç²èéšã«ç£åµããåµåãã幌è«ãçããèãé£ã¹é²ããããææã¯æ¥éã«æªåãæ¿ããçã¿ã䌎ããã¡ãã·ã³ã§ã¯çã«æ¬¡ãã§ç¬ã2çªç®ã«è¢«å®³ã®å€ãåç©ãšããããããã«ãšã£ãŠãç¡èŠã§ããªãè åšãšãªã£ãŠããã
FDAã¯ãããåããç¬ã»ç«ã»åç¬ã»åç«ïŒçåŸ4é±ä»¥äžã»äœéçŽ900g以äžïŒåãã«ãžã§ããªãã¯ã®ããã³ãã©ã é ã®ç·æ¥äœ¿çšèš±å¯ïŒEUAïŒãçºåºããããã®é å€ã¯ååæäžåŸã«æ°æéã§å€ãã®å¹Œè«ãé§é€ã§ãã6æéåŸã«2åç®ãæäžãããå°éå®¶ã¯ãå€ãã®ãããããã§ã«ãã£ã©ãªã¢ã»ããäºé²ã§äœ¿ã£ãŠããã€ãœããµãŸãªã³ç³»ã®è¬ãã©ã»ã³ãŠãžã«ãå¹ãããããé幎ã®è€åäºé²ããç¶ããããšãæå€§ã®é²åŸ¡ã«ãªããšåŒ·èª¿ããŠãããå·å£ãæŸçœ®ãããå±å€æŽ»ååŸã¯äœè¡šãç¹æ€ãããŠãžãèŠã€ãããéããã«ãããã€ãã®ç£å»åž«ã«çžè«ããŠã»ããã
ð·ïž å»çã»çŸç ã»äºé²
2. ðïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
è±ç«ãçå®çªããã1é ââFDAãç¬ã®ãéšé³ææçããšãåé¢äžå®ãã®äž¡æ¹ã«å¹ãåã®é£²ã¿è¬TessieïŒã¿ã·ãããžã³ïŒãæ¿èª
ð 2026.06.04
FDAã¯ãç¬ã®éšé³ææçãšåé¢äžå®ã®åæ¹ãé©å¿ãšããåã®çµå£è¬ãTessieïŒã¿ã·ãããžã³çµå£æ¶²ïŒããæ¿èªãããæå¹æåã®ã¿ã·ãããžã³ã¯Î±2ã¢ãã¬ããªã³å容äœäœåè¬ã§ãææã»äžå®ã«äŒŽã£ãŠé«ã¶ã亀æç¥çµïŒéäºã»éèµ°åå¿ïŒã®æŽ»åãè³ã®ã¬ãã«ã§æãããè±ç«ãªã©ã®éšé³åºæ¿ãäºæ³ããã1æéåããããã¯çå®çªã§ç¬ã1é ã«ãã1æéåã«äžããã®ãåºæ¬çãªäœ¿ãæ¹ã ã
æ¿èªã®æ ¹æ ãšãªã£ãã®ã¯ãå®éšå®€ã§ã¯ãªãå®éã®å®¶åºã§æ¬ç©ã®åŒãéã«ããããŠè¡ããã2ã€ã®è©Šéšã§ãéšé³ææçã®ç¬160é ãåé¢äžå®ã®ç¬224é ã8é±é远跡ãããå ±åãããå¯äœçšã¯ååã»äžç¢ã»ç¡æ°åããããŠé®éã«äŒŽãäžæçãªæŽ»åäœäžã軜ãéå倱調ãªã©ã ã£ããé·ãè±ç«ãçå®çªã«èŠããç¬ã¯å°ãªããªããè¡åä¿®æ£ãã¬ãŒãã³ã°ãšçµã¿åãããããšã§å¹æãé«ãŸããšèãããããæäžã®å¯åŠãéã¯å¿ ãç£å»åž«ãšçžè«ã®ããã§å€æããŠã»ããã
ð·ïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
3. ð ç¬åŠ
ãåãè¬ã§ãå¹ãæ¹ãç¬ã«ãã£ãŠéããã®ã¯ãªããââçç ã119ç¬çš®6,344é ã®éºäŒåãè§£æãè¬ç©ä»£è¬ã®åäœå·®ã®äžç«¯ãè§£æ
ð 2025.10.29
çååŠç ç©¶æã®ç ç©¶ã°ã«ãŒãã¯ãæ±äº¬å€§åŠã®åç©å»çã»ã³ã¿ãŒãå蚺ãã119ç¬çš®ã»6,344é ãšããäžçæå€§èŠæš¡ã®ãµã³ãã«ãçšããè¬ç©ä»£è¬ã«é¢ããéºäŒåCYP2B6ã®é åãè§£æããããã®çµæãé µçŽ ã®ã¯ãããã«åœ±é¿ããã11çš®é¡ã®ããªã¢ã³ãïŒåäœå·®ãçãéºäŒåã®éãïŒãåå®ãããCYP2B6ã¯é®éè¬ãæãŠãããè¬ãªã©ã®ä»£è¬ã«é¢ãããšããããã®æŽ»æ§ãåäœãç¬çš®ã«ãã£ãŠç°ãªãããšããåãè¬ãåãéäžããŠãå¹ãããããå¹ããªãã£ããããäžå ã«ãªãããã
ããã¯ãç¬ã§ã人ãšåãããã«ãè¬ã®å¹ãæ¹ã®åäœå·®ããéºäŒåã¬ãã«ã§èª¬æããããšãã詊ã¿ã§ãå°æ¥çã«ã¯ç¬çš®ãåäœã«å¿ããŠæè¬éãæé©åãããåå¥åå»çãã«ã€ãªããå¯èœæ§ãããã飌ãäž»ã«ãšã£ãŠã¯ãé®éã麻é ãé·ææè¬ã®éã«ããã¡ã®åã¯è¬ã«ææãããããªãããšãã芳å¯ãç£å»åž«ã«äŒããããšããå®å šãªæè¬ã®å©ãã«ãªããæ°ããè¬ãå§ãããšãã¯å°éããæ§åãèŠããç°å€ãããã°ããçžè«ããããšããåºæ¬å§¿å¢ãåŒãç¶ã倧åã ã
ð https://www.riken.jp/press/2025/20251029_2/index.html
4. 𧬠ç ç©¶ã»ç§åŠ
ã·ãã¢ç¬ã®ãå¥åº·å¯¿åœããå·Šå³ãããã®ââå 霢ã®éµã¯é žåã¹ãã¬ã¹ãšçèã®è¡°ããçæŽ»ç¿æ £ã§ããã¬ã€ã«ãã¯é ãããããïŒææ°ç·èª¬ïŒ
ð 2025.09.01
ç¬ãšç«ã®å 霢ãšå¥åº·å¯¿åœïŒãã«ã¹ã¹ãã³ïŒã«é¢ããææ°ã®ç·èª¬ããèåãé§åããäžå¿çãªããã¿ãšããŠãé žåã¹ãã¬ã¹ããšãããã³ã³ããªã¢æ©èœã®äœäžããæããããããã¯ãå 霢ã«äŒŽãéªšæ Œçã®éãšæ©èœã®äœäžã§ããããµã«ã³ããã¢ããã代è¬ã®è¡°ããèªç¥æ©èœã®äœäžãåŒãèµ·ããå ±éã®åŒãéã«ãªãããšããããµã«ã³ããã¢ã¯ãç¬ç«ãè匱åããããã¬ã€ã«ããæ±ºå®ã¥ããéèŠãªèŠå ãšäœçœ®ã¥ããããŠããã
ç·èª¬ã¯ãã·ãã¢æã®å¥åº·ç®¡çãšããŠäœéã®å€åãããã£ã³ã³ãã£ã·ã§ã³ã¹ã³ã¢ïŒBCSïŒãšçèéã¹ã³ã¢ïŒMCSïŒãéåæ©èœïŒæŽåœ¢å€ç§çè©äŸ¡ïŒããããŠèªç¥ã»æ åé¢ã®è©äŸ¡ãããŸãã«ãã§ãã¯ããããšãå§ããŠãããè¿å¹Žã¯NAD+åé§äœãšã»ããªãã£ã¯ã¹ïŒèå现èé€å»è¬ïŒãçµã¿åãããä»å ¥ã§ã飌ãäž»ãè©äŸ¡ããèªç¥æ©èœã®æ¹åã瀺ããç¡äœçºåæ¯èŒè©Šéšãå ±åãããŠãããäºé²çã»åå¥çãªã±ã¢ããã¬ã€ã«ãåããçæŽ»ã®è³ªãæ¯ããå¯èœæ§ã瀺ãããŠããã7æ³ãéããã宿å¥èšºã®é ç®ã«çèéãæ©ãæ¹ãç©å¿ãã®ãã§ãã¯ãå ããæ°ã«ãªãå€åã¯æ©ãã«ç£å»åž«ãžçžè«ãããã
ð https://pmc.ncbi.nlm.nih.gov/articles/PMC12520850/
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ã©ã»ã³ãŠãžçã®ãããªæ°ããå¯çè«ã®è åšããè±ç«ã·ãŒãºã³ã®äžå®ããå ±éããåãã¯ãæ¥é ã®èгå¯ããšãé幎äºé²ãã§ããå·å£ãäœè¡šã®ãã§ãã¯ãããã»ãããäºé²ã®ç¶ç¶ããããŠã·ãã¢ç¬ãªãçèãæ©ãæ¹ã®å€åã«æ°ã¥ãããšââå°ããªæ¥ã ã®èгå¯ããæç¬ã倧ããªãªã¹ã¯ããå®ããŸãã
ð± ç«ãã¥ãŒã¹ â 2026.06.18
æ¬æ¥ 2ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ãFeLVæ€æ»ã¯ç涯1åãã®ã«ãŒã«ãæ€å»ââAAFPãšæ¥æ¬ã®JCASã6幎ã¶ãã«ç«ã®ææçã¬ã€ãã©ã€ã³ãå šé¢æ¹èš
ð 2026.04.01
ç±³åœç«ç£å»åäŒïŒAAFPïŒã𿥿¬èšåºç£å»åŠãã©ãŒã©ã ïŒJCASïŒã¯2026幎4æãç«ã®ææçã¬ã€ãã©ã€ã³ã6幎ã¶ãã«å€§ããæ¹èšãããæå€§ã®å€æŽç¹ã¯ããããŸã§ã®ãåç«ã®ãšãã«FeLVïŒç«çœè¡ç ãŠã€ã«ã¹ïŒïŒFIVãäžåºŠæ€æ»ããŠé°æ§ãªã以åŸã¯äžèŠããšããæ¹éã®æ€å»ã ãæ°ã¬ã€ãã©ã€ã³ã¯ãå€é 飌è²ã®å®¶åºãè±èµ°æŽã®ããç«ãæ°ããè¿ããç«ã«ã€ããŠã¯åæ€æ»ãåŒ·ãæšå¥šããåç«ã®è²æž¡æã«ã¯FeLVæåïŒFIVæäœæ€æ»ãå¿ é ãšããã»ããå€é 飌è²ã«å ããåãš30æ¥åŸãè±èµ°ç¢ºèªã®60æ¥åŸãæ ¢æ§çŸæ£ã®çºçæã«ã¯FeLV-PCRããããŠã·ãã¢æïŒ11æ³ïŒã®å¥åº·èšºææã«ãæ€æ»ããããæ±ããŠããã
æ¹é転æã®æ ¹æ ãšãªã£ãã®ã¯2020ã2025幎ã®è¿œè·¡ç ç©¶ã§ããå®å šå®€å 飌ãããšèªå·±ç³åããå®¶åºã®8.4ïŒ ã§å°ãªããšã1åã®è±èµ°ãèµ·ããŠããããšãæ°ããè¿ããç«ã§PCRã§ããæ€åºã§ããªãæœäŒFeLVãå¢ããŠããããšãã¹ãã¬ã¹ãå ç«æå¶æã«æœäŒãŠã€ã«ã¹ãåæŽ»æ§åããäŸã確èªãããããšãªã©ãæãããããã宀å 飌ãã ããå®å¿ããšæã蟌ãŸããæ°ããç«ãè¿ãããšããè±èµ°ããã£ããšãã¯ããããã€ãã®ç£å»åž«ã«æ€æ»ã®ã¿ã€ãã³ã°ãçžè«ãããã
ð https://carelogy-japan.com/en/columns/feline-infectious-disease-guidelines-2026
ð·ïž å»çã»çŸç ã»äºé²
2. ð± ç«åŠ
ãªãç«ã¯ç¬ããé·çããªã®ãââã倧ããªè³ããšã匷åãªå ç«ç³»ããåºä¹³é¡ã®å¯¿åœãå·Šå³ã46çš®ã®ã²ãã æ¯èŒã§è§£æ
ð 2025.05.08
è±ããŒã¹å€§åŠãçããåœéç ç©¶ããŒã ã¯ãåºä¹³é¡46çš®ã®æå€§å¯¿åœãšãçš®ãè¶ ããŠå ±æãããéºäŒåã察å¿ã¥ããŠè§£æããããã®çµæãè³ã倧ãã寿åœã®é·ãçš®ã»ã©ãå ç«ã«é¢ããéºäŒåã«ããå€ããæè³ãããŠããåŸåãæµ®ãã³äžãã£ããéèŠãªã®ã¯ãåäžã®éºäŒåãçµè·¯ã®å°ããªå€ç°ã§ã¯ãªããéºäŒåãã¡ããªãŒããŸãããšéè€ã»æ¡åŒµãããããªå€§èŠæš¡ãªã²ãã å€åã寿åœã圢ã¥ãã£ãŠãããšããç¹ã ãç«ã¯å€ãã®ç¬çš®ããè³ãšäœéã®æ¯ïŒè³åææ°ïŒãé«ããããã¯åºä¹³é¡ã«ãããŠãã°ãã°é·å¯¿ãšçµã³ã€ãç¹åŸŽã§ããã
ç ç©¶ã¯ãå ç«ç³»ãåã«ç æ°ãšéãã ãã§ãªããåºä¹³é¡ã®é²åã®äžã§ãé·ãçããããšããæ¯ãã圹å²ãæ ã£ãŠããå¯èœæ§ã瀺ããŠãããç«ãå·ãã 现èãããåã»æ¯æ§åããåã«åãé€ãã现èã®æé€ãã«é¢ããéºäŒåãå€ãåããŠããããšãããã®é·å¯¿ãè£ã¥ãããæ¥ã ã®ã±ã¢ã§å¯¿åœã®èšèšå³ãæžãæããããšã¯ã§ããªãããç«ãããšããšãé·çãããããã«é²åããåç©ãã§ããããšãèžãŸããã°ãé©åãªæ é€ã»äœé管çã»å®æå¥èšºã§ãã®çŽ è³ªãæå€§éã«åŒãåºããŠããããã
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ã宀å 飌ãã ããæ€æ»ã¯äžèŠããç«ã¯äžå€«ã§é·çããââã©ã¡ããæ²¹æã¯çŠç©ã§ããè±èµ°ãæ°ããåå± ç«ããã£ããã«ææçãæœãããšãããã°ãé·å¯¿ã®çŽ è³ªãæ¥ã ã®äœé管çãšå¥èšºããã£ãŠããæŽ»ããŸããæç«ã®ç¯ç®ã«ã¯ãæ€æ»ãšå¥åº·ãã§ãã¯ãå¿ããã«ã
æ¯æ7æé ä¿¡

ã³ã¡ã³ããæ®ã